DEF 14A

Company

Arcadia Biosciences, Inc.

Filed

December 27, 2017

Period of Report

January 19, 2018

Accession Number

0001564590-17-025337

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →